Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda

BACKGROUND: Increasing first-line treatment failures in low- and middle-income countries (LMICs) have led to increased use of integrase strand transfer inhibitors (INSTIs) such as dolutegravir. However, HIV-1 susceptibility to INSTIs in LMICs, especially with previous raltegravir exposure, is poorly...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Antimicrob Chemother
Main Authors: Ndashimye, Emmanuel, Avino, Mariano, Olabode, Abayomi S, Poon, Art F Y, Gibson, Richard M, Li, Yue, Meadows, Adam, Tan, Christine, Reyes, Paul S, Kityo, Cissy M, Kyeyune, Fred, Nankya, Immaculate, Quiñones-Mateu, Miguel E, Arts, Eric J
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2020
נושאים:
Original Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7662175/
https://ncbi.nlm.nih.gov/pubmed/32853364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa355
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים